Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Sarcoma 1

Conditions

Gliosarcoma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Temozolomide 128 Radiotherapy 85 Bevacizumab 43 Radiation 30 Carmustine 29 Irinotecan 25 Erlotinib Hydrochloride 22 Magnetic Resonance Spectroscopy 21 Chemotherapy, Adjuvant 20 Surgical Procedures, Operative 15 O(6)-benzylguanine 15 Carboplatin 14 sargramostim 12 Radiotherapy, Intensity-Modulated 12 Radiotherapy, Conformal 12 Sirolimus 10 Imatinib Mesylate 9 Filgrastim 9 Drug Therapy 9 temsirolimus 8 pembrolizumab 8 Thalidomide 8 Sorafenib 8 Radiosurgery 8 Gefitinib 8 motexafin gadolinium 7 aldesleukin 7 Procarbazine 7 Gene Expression Profiling 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × Basiliximab × Sarcoma × Clear all

NCT00626483 2021-03-09

REGULATe

Duke University

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡